CAS 164658-13-3
:3-[(4-{2-[(3-clorofenil)amino]pirimidin-4-il}piridin-2-il)amino]propan-1-ol
- 3-(4-(2-(3-Chlorophenylamino)Pyrimidin-4-Yl)Pyridin-2-Ylamino)Propanol
1-Propanol, 3-[[4-[2-[(3-chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-
CAS:Fórmula:C18H18ClN5OPureza:99%Forma y color:SolidPeso molecular:355.82143-((4-(2-((3-Chlorophenyl)Amino)Pyrimidin-4-Yl)Pyridin-2-Yl)Amino)Propan-1-Ol
CAS:3-((4-(2-((3-Chlorophenyl)Amino)Pyrimidin-4-Yl)Pyridin-2-Yl)Amino)Propan-1-OlPureza:98%Peso molecular:355.82g/molCGP 60474
CAS:Producto controladoApplications CGP 60474 is type of protein kinase C inhibitor (ckd1/cdk2) used in the treatment of different cancers
References Stanetty, P. et al.: J. Org. Chem., 70, 5215 (2005);Fórmula:C18H18ClN5OForma y color:NeatPeso molecular:355.821CGP60474
CAS:CGP60474 is an inhibitor of VEGFR-2 (IC50 = 84 nM) and an inhibitor of ATP-competitive PKC.Fórmula:C18H18ClN5OPureza:98.81%Forma y color:SolidPeso molecular:355.82Ref: TM-T14943
1mg34,00€2mg46,00€5mg71,00€10mg92,00€25mg177,00€50mg314,00€100mg518,00€1mL*10mM (DMSO)78,00€CGP 60474
CAS:CGP 60474 is a neurotrophic factor that has been shown to be beneficial for the treatment of inflammatory bowel disease. It binds to intracellular targets, such as kinases, and prevents them from being activated by other molecules. CGP 60474 has also been used in diagnosis of autoimmune diseases and HIV infection. CGP 60474 is a combination preparation with an inhibitor of viral replication that is active against HIV-1, HIV-2, and SIV. The drug inhibits viral replication by binding to the viral envelope protein gp120 and preventing it from binding to the host CD4 receptor on T cells. This prevents viral entry into the cell and subsequent integration into the host genome.
Fórmula:C18H18ClN5OPureza:Min. 95%Peso molecular:355.82 g/molRef: 3D-PGA65813
Producto descatalogado





